HQTC(688151)2024-04-26 11:34Financial Corrections - The company corrected its financial reports for 2021, 2022, and the first half of 2023 due to insufficient revenue recognition, inadequate inventory impairment provisions, and cross-period cost issues, affecting revenue, costs, and profits without changing the overall profit or loss nature[2][3][13]. - For the 2021 annual report, the company reduced accounts receivable and revenue by CNY 526,460.17, adjusted net profit down by CNY 1,031,377.67, and decreased retained earnings by CNY 928,239.90[6][13]. - In the 2022 annual report, the company adjusted revenue down by CNY 23,727,654.87 and reduced net profit by CNY 4,361,070.62, while also increasing inventory impairment losses by CNY 12,492,262.60[9][10][13]. - The adjustments resulted in a net profit impact of -CNY 103.14 million for 2021, +CNY 103.14 million for the first half of 2022, -CNY 436.11 million for 2022, and -CNY 64.84 million for the first half of 2023[13]. Financial Metrics Adjustments - The company's accounts receivable decreased by CNY 500,137.16 to CNY 605,029,206.66 as a result of the corrections[15]. - Inventory increased by CNY 526,460.17 to CNY 181,744,196.07 following the adjustments[15]. - The company’s deferred tax assets were adjusted by CNY 16,086.12, resulting in a new total of CNY 26,508,653.00[15]. - The adjustments to accounts payable increased by CNY 1,073,786.80, bringing the total to CNY 329,525,531.34[15]. - The company's total revenue for the fiscal year 2021 was adjusted to approximately CNY 1,274.72 million, reflecting a decrease of 0.04% due to corrections[16]. - For the first half of 2022, the adjusted revenue was CNY 343.65 million, an increase of 0.15% compared to the previous figure[18]. - The net profit for the fiscal year 2022 was revised to CNY 68.07 million, showing a decrease of 6.02% after adjustments[21]. - As of June 30, 2023, the company's total assets were reported at approximately CNY 5,080.50 million, reflecting a slight increase of 0.03%[24]. - The adjusted net profit for the first half of 2023 was CNY 28.32 million, a decrease of 2.24% compared to the previous figure[24]. - The company's total liabilities as of December 31, 2022, were adjusted to CNY 376.72 million, reflecting a minor increase of 0.18%[21]. - The adjusted gross profit margin for the fiscal year 2022 was reported at 26.0%, indicating a decrease from the previous year[21]. - The company experienced a significant increase in asset impairment losses, with a correction showing a decrease of 454.65% for the fiscal year 2022[21]. Project Investments - The cumulative investment in the "New Type Nuclear Biological Emergency Rescue Protective Equipment Industrialization Production Base" project was adjusted to ¥21,934,822.38, with a progress rate of 2.84%[26]. - The cumulative investment in the "New Type Nuclear Biological Protective Basic Material R&D Platform Construction Project" was adjusted to ¥1,341,866.00, with a progress rate of 0.38%[26]. Management and Compensation - The total remuneration for key management personnel was corrected to ¥697.56 million for the current period, up from ¥603.19 million[28]. - The total remuneration for non-independent directors and supervisors was disclosed as ¥943,700 in the 2022 annual report[28]. - The company reported additional related party transactions totaling ¥1,566,379.33 for employee compensation with China Weapon Equipment Group Co., Ltd.[29]. Compliance and Future Measures - The audit committee confirmed that the corrections made to the financial reports comply with relevant accounting standards and accurately reflect the company's financial status[31]. - The supervisory board agreed that the corrections to the financial data do not harm the interests of the company and its shareholders[32]. - The accounting firm confirmed that the company's handling of the accounting errors aligns with the applicable accounting standards[33]. - The company plans to enhance supervision and training on financial accounting practices to prevent future issues[34]. - The company expressed apologies for any inconvenience caused to investors due to the financial reporting errors[34].